GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates

Impact · against what's priced in

GEHC's Q3 beat is marginally positive but largely confirms the baseline growth the market already expects. While revenue growth of 7.2% slightly exceeds the 4.8% the market currently assumes, it remains below the 8.7% CAGR required for a valuation re-rating.

GEHC+0.10

Challenges what's priced in

The price assumes

The 4.8% overall revenue growth... which match the endorsed models near $67.